Key result
Mitral annular disjunction was not associated with an increased risk of mortality or other adverse clinical outcomes post mitral valve surgery compared to patients without the abnormality.
Why the study?
Little is known about the significance of mitral annular disjunction (MAD) in patients requiring mitral valve surgery.
Does the presence of mitral annular disjunction affect clinical and echocardiographic outcomes in patients undergoing mitral valve surgery?
Observational (n=185)
No
Does the presence of mitral annular disjunction affect clinical and echocardiographic outcomes in patients undergoing mitral valve surgery?
Mitral annular disjunction is common in patients undergoing mitral valve surgery, is typically corrected by the procedure, and does not increase the risk of adverse clinical or arrhythmic outcomes.
Answers are grounded in this paper and cite their sources.
No excess mortality or AF risk observed with MAD after mitral surgery; leaves open whether preoperative identification warrants modified protocols.
BACKGROUND: Mitral annular disjunction (MAD) is a structural abnormality characterized by the distinct separation of the mitral valve annulus/left atrium wall and myocardium. Little is known about the significance of MAD in patients requiring mitral valve surgery. This evaluation evaluates the echocardiographic characteristics and patient outcomes for patients with and without MAD who require mitral valve surgery. METHODS: All patients who underwent mitral valve surgery and who had a pre-surgical transthoracic echocardiogram between 2013 and 2020 were included. Patient demographics and clinical outcomes were collected on review of patient electronic records. RESULTS: A total of 185 patients were included in the analysis of which 32.4% had MAD (average MAD length 8.4 mm). MAD was seen most commonly in patients with mitral valve prolapse and myxomatous mitral valves disease (90% and 60% respectively). In the patients with MAD prior to mitral valve surgery, only 3.9% had MAD post mitral valve surgery. There were no significant difference in the severity of post-operative mitral regurgitation, arrhythmic events or major adverse cardiovascular events in patients with and without MAD. CONCLUSIONS: MAD is common in patients who undergo mitral valve surgery. Current surgical techniques are able to correct the MAD abnormality in the vast majority of patients. MAD is not associated with an increased risk of adverse clinical outcomes post mitral valve surgery.
No takes yet. Share an insight, caveat, or question.
Bennett et al. (2022) conducted an observational in Mitral valve disease requiring surgery (n=185). Mitral annular disjunction vs. No mitral annular disjunction was evaluated on Mortality (p=0.85). Mitral annular disjunction was not associated with an increased risk of mortality or other adverse clinical outcomes post mitral valve surgery compared to patients without the abnormality.
Synapse has enriched 10 related papers. Consider them for comparative context: